Navigation Links
Collegium Pharmaceutical Announces Relocation to Massachusetts
Date:1/17/2013

CANTON, Mass., Jan. 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the relocation of its corporate offices and laboratory facilities to Canton, Massachusetts from Cumberland, Rhode Island.

The Company's lead development program is Oxycodone DETERx® (COL-003), a tamper-resistant, extended-release oxycodone product utilizing its proprietary DETERx® technology. The Oxycodone DETERx® formulation was specifically designed to provide and preserve extended release of the active ingredient following the most common methods of product tampering employed by drug abusers (e.g., crushing, chewing, heating for IV injection, etc.). The product is currently in the final stage of clinical development and has been designated Fast Track Status by the FDA due to its potential to address the problem of prescription drug abuse, a major public health issue in the U.S.

Extended-release formulations of opioids (e.g., OxyContin®) are known to be attractive targets for non-medical use since they contain large doses of drug. Crushing these dosage forms can defeat the extended-release properties and result in immediate availability of the opioid, also known as "dose dumping." Crushed formulations are commonly self-administered by abusers orally, intranasally or by IV injection, resulting in a "high." Although marketed formulations carry labels warning against crushing and breaking, there are reports of legitimate pain patients crushing tablets to facilitate swallowing, a practice that significantly increases their risk of serious adverse events.

"We are pleased to have completed our relocation to Massachusetts. The new analytical and development labs will facilitate the completion
'/>"/>

SOURCE Collegium Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Collegium Pharmaceutical to Present at Piper Jaffrays 24th Annual Healthcare Conference
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
4. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
9. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
10. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
11. Icahn Issues Statement Regarding Amylin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 The Coalition of State ... and regional professional rheumatology societies, today released the ... explored perceptions of biosimilars and the potential impact ... Biosimilars are medicines that are highly similar, ... notably different from generic medications in that it ...
(Date:7/1/2015)... INDIANAPOLIS , July 1, 2015 Eli Lilly ... results for the second quarter of 2015 on Thursday, July ... that day with the investment community and media to further ... will begin at 9 a.m. EDT. Investors, media and the ... call through a link that will be posted on Lilly,s ...
(Date:7/1/2015)... According to a new market research report ... Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Polymeric, Polyurethane), by Application ... 2020", published by MarketsandMarkets, the global Surgical Sealants and ... 2020, growing at a CAGR of 9.2% during the ... 119 market T ables and 29 ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 2Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 3Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 4
... MONTRÉAL, June 1, 2007 – Thallion Pharmaceuticals Inc.,(TSX: ... Phase,I/II clinical trial investigating ECO-4601 in advanced cancer,patients ... the American,Society of Clinical Oncology (ASCO) Annual Meeting ... portion of the study, 14,patients (ten colorectal, two ...
... -- Data Presented at Annual Meeting of the ... Calif. -- June 4, 2007 -- SciClone Pharmaceuticals,Inc. ... product candidate thymalfasin (ZADAXIN(r), thymosin,alpha 1) achieved its ... patients diagnosed with stage IV malignant melanoma, the,most ...
Cached Medicine Technology:Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3
(Date:7/2/2015)... ... July 02, 2015 , ... ... providers, has been retained to lead a national chief operating officer recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... overall status of the Gelatin Capsule manufacturers. The report is a valuable source ... The report depicts the global and Chinese market for the Gelatin Capsule industry ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... solutions for drugs, biologics and consumer health products, today announced that it has ... Irmgard Neuper is the new General Manager at Catalent’s Schorndorf facility, which provides ...
(Date:7/2/2015)... ... July 02, 2015 , ... Today, East Liverpool City Hospital ... Center at East Liverpool City Hospital (ELCH). Pam is currently the Chief Nursing Officer ... director of surgery. Pam holds a master’s degree in health care administration as well ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... Garramone introduced CoolSculpting Plus, an advanced approach to body contouring. CoolSculpting ... to 44%. , About the basic CoolSculpting procedure:, The CoolSculpting procedure ...
Breaking Medicine News(10 mins):Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 2Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 4
... the Democrats, supermajority necessary to pass comprehensive national ... promote greater efficiency in the medical delivery system. ... accelerate delivery system change but would be highly ... proposals that provide new authority for the Centers ...
... ... ... ... ...
... ... ... ... ...
... heart disease most susceptible to potential problems, small study suggests ... raise the risk for experiencing heartbeat irregularities among older individuals ... , The finding stems from an assessment of a small ... of heart disease -- who were observed in an environment ...
... ... lawyer, David Perecman, questions whether anyone should continue driving them before having them fixed. , ... New York (PRWEB) March 4, 2010 -- In ... New York Post , Jerry Silver, 86, lost control of his car and collided with ...
... warmer than 75 degrees poses added risks , THURSDAY, March ... deaths in New York City go up with the temperature: ... 75 degrees Fahrenheit. , The findings, published online March ... death statistics in the city from 1990 through 2006. , ...
Cached Medicine News:Health News:Experts support new federal center for Medicare and Medicaid innovation 2Health News:SarahCare(R) and Posit Science Corporation(R) Join Forces to Bring Brain Fitness to Seniors at SarahCare(R) of Minnesota 2Health News:SarahCare(R) and Posit Science Corporation(R) Join Forces to Bring Brain Fitness to Seniors at SarahCare(R) of Minnesota 3Health News:SarahCare(R) and Posit Science Corporation(R) Join Forces to Bring Brain Fitness to Seniors at SarahCare(R) of Minnesota 4Health News:SarahCare(R) and Posit Science Corporation(R) Join Forces to Bring Brain Fitness to Seniors at SarahCare(R) of Minnesota 5Health News:National Healthcare Leaders in San Francisco to Address Health Reform and Payment Reform 2Health News:National Healthcare Leaders in San Francisco to Address Health Reform and Payment Reform 3Health News:National Healthcare Leaders in San Francisco to Address Health Reform and Payment Reform 4Health News:Air Travel Could Raise Risk for Heartbeat Irregularities 2Health News:Air Travel Could Raise Risk for Heartbeat Irregularities 3Health News:New York Personal Injury Lawyers Concerned About Toyota Accident in Queens 2Health News:New York Personal Injury Lawyers Concerned About Toyota Accident in Queens 3
... Fibrin Sealant has been shown to be ... Containing uniform, reproducible concentrations of fibrinogen and ... final stage of the coagulation cascade to ... firmly adheres to connective tissue like a ...
... catheter is inserted into the subclavian or ... vena cava. The Cool Line incorporates ... temperature-controlled saline flowing within a closed-loop design, ... circulation. The Cool Line combines two ...
... The Fortius catheter provides maximum ... to target temperature. The Fortius catheter ... design to provide the ultimate solution ... catheter is inserted percutaneously into the ...
...
Medicine Products: